Community hub
Recent from talks
Knowledge base stats:
Talk channels stats:
Members stats:
Patient safety organization
A patient safety organization (PSO) is an organization that seeks to improve medical care by advocating for the reduction of medical errors. Common functions of patient safety organizations include health care data collection, reporting and analysis on health care outcomes, educating providers and patients, raising funds to improve health care, and advocating for safety-oriented policy changes. In the United States, the term typically refers only to PSOs that have been formally recognized by the Secretary of Health and Human Services and listed with the Agency for Healthcare Research and Quality. A federally-designated PSO differs from a typical PSO in that it provides health care providers in the U.S. privilege and confidentiality protections in exchange for efforts to improve patient safety.[citation needed]
In the 1990s, reports in several countries revealed a staggering number of patient injuries and deaths each year due to avoidable errors and deficiencies in health care, among them adverse events and complications arising from poor infection control. In the United States, a 1999 report from the Institute of Medicine called for a broad national effort to prevent these events, including the establishment of patient safety centers, expanded reporting of adverse events, and development of safety programs in healthcare organizations. Although many PSOs are funded and run by governments, others have sprung from private entities such as industry, professional, health insurance providers, and consumer groups.
The functions of a PSO can be diverse, but the United States government formally defines "patient safety activities" as:
In response to a 2002 World Health Assembly Resolution, the World Health Organization (WHO) launched the World Alliance for Patient Safety in October 2004. The goal was to develop standards for patient safety and assist UN member states to improve the safety of health care. The Alliance raises awareness and political commitment to improve the safety of care and facilitates the development of patient safety policy and practice in all WHO Member States. Each year, the Alliance delivers a number of programs covering systemic and technical aspects to improve patient safety around the world.
At the Fifty-Ninth World Health Assembly in May 2006, the Secretariat reported that the Alliance held patient safety meetings in five of the six WHO regions and 40 technical workshops in 18 countries. Since the launch of the Alliance in October 2004, significant progress was achieved in six areas:
Patients for Patient Safety is part of the World Alliance for Patient Safety launched in 2004 by the WHO. The project emphasizes the central role patients and consumers can play in efforts to improve the quality and safety of healthcare around the world. PFPS works with a global network of patients, consumers, caregivers, and consumer organizations to support patient involvement in patient safety programs, both within countries and in the global programs of the World Alliance for Patient Safety.
The Therapeutic Goods Administration (TGA) is a unit of the Australian Government Department of Health and Ageing. The TGA approves and monitors prescription and non-prescription drugs (including herbal products), medical supplies and devices and blood and biological products. Risks to users are assessed prior to product introduction, and manufacturers are regularly audited for efficacy, quality and safety. Manufacturers are required to report adverse drug effects to the Adverse Drug Reactions Advisory Committee (ADRAC) of the TGA; reporting by medical professionals and consumers is voluntary. ADRAC notifies medical professionals and the public through recalls and alerts on its website and publications.
In December 2003, the Australian and New Zealand Governments signed an agreement to establish a joint regulatory organization for therapeutic products. The Australia New Zealand Therapeutic Products Authority (ANZTPA) will replace the Australian Therapeutic Goods Administration (TGA) and the New Zealand Medicines and Medical Devices Safety Authority (Medsafe), and be accountable to the Australian and New Zealand Governments. Implementing legislation is scheduled for introduction into both countries' parliaments in July 2006.
Hub AI
Patient safety organization AI simulator
(@Patient safety organization_simulator)
Patient safety organization
A patient safety organization (PSO) is an organization that seeks to improve medical care by advocating for the reduction of medical errors. Common functions of patient safety organizations include health care data collection, reporting and analysis on health care outcomes, educating providers and patients, raising funds to improve health care, and advocating for safety-oriented policy changes. In the United States, the term typically refers only to PSOs that have been formally recognized by the Secretary of Health and Human Services and listed with the Agency for Healthcare Research and Quality. A federally-designated PSO differs from a typical PSO in that it provides health care providers in the U.S. privilege and confidentiality protections in exchange for efforts to improve patient safety.[citation needed]
In the 1990s, reports in several countries revealed a staggering number of patient injuries and deaths each year due to avoidable errors and deficiencies in health care, among them adverse events and complications arising from poor infection control. In the United States, a 1999 report from the Institute of Medicine called for a broad national effort to prevent these events, including the establishment of patient safety centers, expanded reporting of adverse events, and development of safety programs in healthcare organizations. Although many PSOs are funded and run by governments, others have sprung from private entities such as industry, professional, health insurance providers, and consumer groups.
The functions of a PSO can be diverse, but the United States government formally defines "patient safety activities" as:
In response to a 2002 World Health Assembly Resolution, the World Health Organization (WHO) launched the World Alliance for Patient Safety in October 2004. The goal was to develop standards for patient safety and assist UN member states to improve the safety of health care. The Alliance raises awareness and political commitment to improve the safety of care and facilitates the development of patient safety policy and practice in all WHO Member States. Each year, the Alliance delivers a number of programs covering systemic and technical aspects to improve patient safety around the world.
At the Fifty-Ninth World Health Assembly in May 2006, the Secretariat reported that the Alliance held patient safety meetings in five of the six WHO regions and 40 technical workshops in 18 countries. Since the launch of the Alliance in October 2004, significant progress was achieved in six areas:
Patients for Patient Safety is part of the World Alliance for Patient Safety launched in 2004 by the WHO. The project emphasizes the central role patients and consumers can play in efforts to improve the quality and safety of healthcare around the world. PFPS works with a global network of patients, consumers, caregivers, and consumer organizations to support patient involvement in patient safety programs, both within countries and in the global programs of the World Alliance for Patient Safety.
The Therapeutic Goods Administration (TGA) is a unit of the Australian Government Department of Health and Ageing. The TGA approves and monitors prescription and non-prescription drugs (including herbal products), medical supplies and devices and blood and biological products. Risks to users are assessed prior to product introduction, and manufacturers are regularly audited for efficacy, quality and safety. Manufacturers are required to report adverse drug effects to the Adverse Drug Reactions Advisory Committee (ADRAC) of the TGA; reporting by medical professionals and consumers is voluntary. ADRAC notifies medical professionals and the public through recalls and alerts on its website and publications.
In December 2003, the Australian and New Zealand Governments signed an agreement to establish a joint regulatory organization for therapeutic products. The Australia New Zealand Therapeutic Products Authority (ANZTPA) will replace the Australian Therapeutic Goods Administration (TGA) and the New Zealand Medicines and Medical Devices Safety Authority (Medsafe), and be accountable to the Australian and New Zealand Governments. Implementing legislation is scheduled for introduction into both countries' parliaments in July 2006.